EMMA MARTIN: Open Payments
NPI 1063042075 · ALPHARETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 26 payments from 12 companies in 2025. Trend: 2023 $1,293 · 2024 $719 · 2025 $755
Food & beverage: $555Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $228 |
| ABBVIE INC. | 9 | $216 |
| MERZ NORTH AMERICA, INC. | 2 | $63 |
| GENZYME CORPORATION | 1 | $37 |
| UCB, Inc. | 2 | $34 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $31 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Galderma Laboratories, L.P. | 1 | $21 |
Products named: TREMFYA, BOTOX, Xeomin, RINVOQ, DUPIXENT, Bimzelx, Rhapsido, GVOKE HYPOPEN.
Industry payments across GA — which companies pay providers there.
